These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30616019)

  • 21. The Use of Cannabinoids in Treating Dementia.
    Weier M; Hall W
    Curr Neurol Neurosci Rep; 2017 Aug; 17(8):56. PubMed ID: 28631194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probucol prevents blood-brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet.
    Mamo JC; Lam V; Brook E; Mooranian A; Al-Salami H; Fimognari N; Nesbit M; Takechi R
    Diab Vasc Dis Res; 2019 Jan; 16(1):87-97. PubMed ID: 30156119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.
    Bertram S; Brixius K; Brinkmann C
    Endocrine; 2016 Aug; 53(2):350-63. PubMed ID: 27160819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 2 diabetes, cognitive function and dementia: vascular and metabolic determinants.
    van den Berg E; Kessels RP; Kappelle LJ; de Haan EH; Biessels GJ;
    Drugs Today (Barc); 2006 Nov; 42(11):741-54. PubMed ID: 17171193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive agents do not prevent blood-brain barrier dysfunction and cognitive deficits in dietary-induced obese mice.
    Mamo JCL; Lam V; Giles C; Coulson SH; Fimognari N; Mooranian A; Al-Salami H; Takechi R
    Int J Obes (Lond); 2017 Jun; 41(6):926-934. PubMed ID: 28239165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of exercise on type 2 diabetes-associated cognitive impairment in rats.
    Mehta BK; Singh KK; Banerjee S
    Int J Neurosci; 2019 Mar; 129(3):252-263. PubMed ID: 30231786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ameliorative effects of exercise on cognitive impairment and white matter injury from blood-brain barrier disruption induced by chronic cerebral hypoperfusion in adolescent rats.
    Lee JM; Park JM; Song MK; Oh YJ; Kim CJ; Kim YJ
    Neurosci Lett; 2017 Jan; 638():83-89. PubMed ID: 27956237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 2 diabetes and cognitive impairment: linking mechanisms.
    Luchsinger JA
    J Alzheimers Dis; 2012; 30 Suppl 2(0):S185-98. PubMed ID: 22433668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes is an independent risk factor for dementia conversion in patients with mild cognitive impairment.
    Ciudin A; Espinosa A; Simó-Servat O; Ruiz A; Alegret M; Hernández C; Boada M; Simó R
    J Diabetes Complications; 2017 Aug; 31(8):1272-1274. PubMed ID: 28545893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.
    Janelidze S; Hertze J; Nägga K; Nilsson K; Nilsson C; ; Wennström M; van Westen D; Blennow K; Zetterberg H; Hansson O
    Neurobiol Aging; 2017 Mar; 51():104-112. PubMed ID: 28061383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cognitive dysfunction and dementia associated with elderly diabetes].
    Kouta Y; Sakurai T; Yokono K
    Nihon Rinsho; 2006 Jan; 64(1):119-23. PubMed ID: 16408458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine Attenuates Disruption of Blood-Brain Barrier Induced by Saturated-Fat Feeding in Wild-Type Mice.
    Elahy M; Lam V; Pallebage-Gamarallage MM; Giles C; Mamo JC; Takechi R
    Nicotine Tob Res; 2015 Dec; 17(12):1436-41. PubMed ID: 25744960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Nakagawa T; Hasegawa Y; Uekawa K; Kim-Mitsuyama S
    Exp Gerontol; 2017 Jan; 87(Pt A):108-112. PubMed ID: 27916702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-brain barrier damage in vascular dementia.
    Ueno M; Chiba Y; Matsumoto K; Murakami R; Fujihara R; Kawauchi M; Miyanaka H; Nakagawa T
    Neuropathology; 2016 Apr; 36(2):115-24. PubMed ID: 26607405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective.
    Simó R; Ciudin A; Simó-Servat O; Hernández C
    Acta Diabetol; 2017 May; 54(5):417-424. PubMed ID: 28210868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic perspective on vascular cognitive impairment.
    Toyama K; Spin JM; Mogi M; Tsao PS
    Pharmacol Res; 2019 Aug; 146():104266. PubMed ID: 31108183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sugar in mind: Untangling a sweet and sour relationship beyond type 2 diabetes.
    Cherbuin N; Walsh EI
    Front Neuroendocrinol; 2019 Jul; 54():100769. PubMed ID: 31176793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurovascular coupling in cognitive impairment associated with diabetes mellitus.
    Mogi M; Horiuchi M
    Circ J; 2011; 75(5):1042-8. PubMed ID: 21441696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sigma-1 receptor activation alleviates blood-brain barrier dysfunction in vascular dementia mice.
    Liu DY; Chi TY; Ji XF; Liu P; Qi XX; Zhu L; Wang ZQ; Li L; Chen L; Zou LB
    Exp Neurol; 2018 Oct; 308():90-99. PubMed ID: 30006137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.